Forrest Fleming

Forrest Fleming has a distinguished career in creating successful disruptive technology companies across a diverse industry portfolio. He specializes in creating, funding, and executing business plans to optimally commercialize world-changing innovation.

Prior to joining BioProtonics in March 2023, Mr. Fleming was Founder and CEO for TrueVision Surgical (robotic digital surgery) in Santa Barbara CA from 2006 to 2018. TrueVision was acquired by Alcon/Novartis in December 2018, which included an exclusive IP license to True Digital Surgery (TDS; a new Company spin out) to pursue non-ophthalmology surgical markets. Prior to TrueVision, Mr. Fleming was Founder and CEO of ScentAir Technologies, a pioneer in creating scent-marketing solutions for retail environments and brand building. He also has held senior sales and marketing positions for several successful early-stage Companies including Parametric Technology (Pro Engineer-Solidworks CAD software), Celera Genomics (drug discovery).  His early career was spent in various sales and sales management roles for several technology companies including Hewlett Packard.

Forrest holds a B.S. degree in Industrial Technology from California Polytechnic University at San Luis Obispo, California and remains a passionate alumnus and supporter, serving in various advisory capacities.